Medical University | MUSC Hospital | College of Medicine | Directory

Department of Psychiatry and Behavioral Sciences

MUSC logo

ART

Department of Psychiatry

Clinical

Research

Training

Faculty

Development

Contact Us

Directions

About Charleston





   

   

   

  

 « back to January calendar

        Paula Riggs, M.D.

     
SPEAKER BIO
  

Paula Riggs, M.D., is an Associate Professor in the Department of Psychiatry at the University of Colorado at Denver and the Health Sciences Center (UCDHSC).  She has also been the Director of Psychiatric Services for Adolescents at UCDHSC-affiliated Addiction, Research and Treatment Services (ARTS), for the past decade. Dr. Riggs’ research career has focused on the development and testing of effective pharmacotherapy and behavioral treatment interventions in adolescents with substance use disorders and psychiatric comorbidity. More recently her research has expanded to multi-site effectiveness trials of combined pharmacotherapy and behavioral interventions conducted in community-based treatment settings. She has been the Principal Investigator on a number of NIH/NIDA-funded research grants including a recently completed randomized controlled trial of fluoxetine vs placebo + cognitive behavioral therapy (CBT) in depressed, substance dependent adolescents. She is also currently the Principal Investigator of a multi-site trial in NIDA’s Clinical Trials Network (CTN): A Randomized Controlled Trial of OROS-MPH for ADHD in Adolescents with Substance Use Disorders. She is the author of numerous publications and educational articles and monographs in the field of adolescent treatment research.  In addition to her clinical treatment research she is also plays an active role in mentoring, teaching, and training medical students, psychiatric residents, and junior faculty within her own academic institution as well as nationally. She is the Principal Investigator of the NIDA/AACAP K 12 Physician Scientist Career Development Award, the purpose of which is to provide training for 5 child psychiatrists to become career investigators in the area of pediatric addiction research.

   
OBJECTIVES                                                                                                                                                               
        At the completion of this session, the participant should be able to:
       1) Identify developmental antecedents, trajectories and bidirectional relationship between
    psychiatric comorbidity and substance abuse in adolescents.
2) Discuss current research support for integrated treatment of adolescent substance use
    disorders and co-occurring  psychiatric disorders, including results of recent
    randomized controlled trial of fluoxetine and CBT for MDD in adolescents with
    behavior problems and substance use disorders and preliminary results from
    randomized controlled trial of OROS MPH and CBT for ADHD in adolescents with
    substance use Disorders.
3) Discuss the implications of this research for clinical practice and future research,
    including an evidence-based integrated treatment model for adolescents with co-occurring
    disorders.
Links

Psychiatry Intranet

Institute of Psychiatry

Psychiatry Associates

College of Medicine

MUSC Homepage



News and Events

Message from the Chairman

Residents 2009-2010

Grand Rounds Schedule

Events